drugset / Trial / NCT02721563
A Trial of CMNa Combined With Definitive Concurrent Chemoradiotherapy for Locally Advanced ESCC
RandomizedParallel-groupSingle-blindTreatment
Summary
This is a perspective, multicenter,randomized controlled trial to evaluate the efficacy and safety of treatment with CMNa combined with concurrent chemoradiotherapy in patients with locally advanced squamous cell esophageal carcinoma . Analyses of primary objective (ORR) will be done as defined in the protocol.
Timeline
- Start
- 2016-02-25
- Primary completion
- 2018-06-10
- Completion
- 2018-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Sodium Glycididazole | Small molecule | 700 mg/m2 | Intravenous |